T2 Biosystems Regains Nasdaq Compliance
T2 Biosystems, Inc. (TTOO) today announced that on October 31, 2023 it received written notice from the Nasdaq Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating...
Neutral
or
T2 Biosystms Inc News & Analysis
-
-
T2 Biosystems Announces Amendment and Extension of CRG Term Loan Agreement
T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the successful amendment and extension to its Term...
-
Earnings call: T2 Biosystems eyes multi-billion dollar opportunity amid Q3 financial results
T2 Biosystems (NASDAQ:TTOO) recently held an earnings call to discuss preliminary financial results for Q3 2023 and provide a business update. Despite a decline in revenue due to a sepsis...
-
T2 Biosystems shares dive on weak Q3 earnings and reverse stock split
Shares of T2 Biosystems (NASDAQ:TTOO) (NASDAQ: TT00), a diagnostics company specializing in sepsis and antibiotic resistance detection, plunged by 53% today following the release of...
-
T2 Biosystems Shares Plunge Amid Weak Q3 Outlook and Backorders
Shares of T2 Biosystems (NASDAQ:TTOO) plummeted 47% to $9.19 this Friday due to disappointing third-quarter earnings projections. This steep decline marks a year-to-date drop of an alarming...
-
T2 Biosystems announces preliminary Q3 total revenue of $1.5 million
T2 Biosystems, Inc. (TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial...
-
T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel for Detection of Acinetobacter baumannii
T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification...
-
T2 Biosystems Announces Reverse Stock Split Effective Today
T2 Biosystems, Inc. (TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that the Company’s board of directors...
-
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat Panel
T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has received 510(k) clearance from the U.S....
-
T2 Biosystems Announces 141.6M Share Offering by Selling Stockholders
T2 Biosystems (NASDAQ:TTOO) has filed for up to 141,643,058 share offering by selling stockholders.
-
T2 Biosystems Regains Nasdaq Compliance
T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it received written...
-
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirements
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Nasdaq Hearings Panel (the “Panel”)...
-
T2 Biosystems Receives FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today the U.S. Food and Drug Administration (FDA)...
-
Canaccord Genuity maintains T2 Biosystms Inc at 'hold' with a price target of $0.12
An analyst from Canaccord Genuity maintained T2 Biosystms Inc (NASDAQ: TTOO) at 'hold' with a price target of $0.12 from a prior price target of $0.20. Prior to this rating, T2 Biosystms...
-
T2 Biosystems Reports Prelim Q2 Revenue of $2M
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced preliminary unaudited financial and...
-
T2 Biosystems Announces Clinical Collaboration with Vanderbilt University Medical Center to Implement and Evaluate the T2Bacteria Panel for Clinical Use
T2 Biosystems, Inc. (NASDAQ:TTOO) today announced a collaborative relationship with Vanderbilt University Medical Center’s (VUMC) Learning Healthcare System (LHS) Platform, which unites...
-
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted an application with the...
-
T2 Biosystems Announces Second Largest Sepsis-Driven Instrument Sale in Company History
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the second largest sale of sepsis-driven T2Dx®...
-
Canaccord Genuity maintains T2 Biosystms Inc at 'hold' with a price target of $0.20
An analyst from Canaccord Genuity maintained T2 Biosystms Inc (NASDAQ: TTOO) at 'hold' with a price target of $0.20 from a prior price target of $0.50. Prior to this rating, T2 Biosystms...
-
T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel
T2 Biosystems, Inc. (TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification...
-
T2 Biosystems Announces Exploration of Strategic Alternatives, Cuts 30% Staff
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced it has initiated a process to explore a range...
-
T2 Biosystems Halted, News Pending
T2 Biosystems (TTOO) Halted, News Pending
-
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.11%
Investing.com – U.S. stocks were higher after the close on Wednesday, as gains in the Consumer Services, Industrials and Consumer Goods sectors led shares higher. At the close in NYSE, the...
-
T2 Biosystems Prices 11.11M Share Offering at $1.08/sh
T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of its previously announced underwritten public offering of 11,111,111 shares of common stock (or common stock equivalents) and...
-
T2 Biosystems Misses Q2 EPS by 1c
T2 Biosystems (NASDAQ:TTOO) reported Q2 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $5.9 million versus the consensus estimate of...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.00%
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Healthcare, Technology and Basic Materials sectors propelled shares higher while losses in the Telecoms, Oil...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.85%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Telecoms, Technology and Basic Materials sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.93%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Technology and Oil & Gas sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.23%
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Basic Materials, Consumer Goods and Telecoms sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.16%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Consumer Services, Telecoms and Utilities sectors propelled shares lower. At the close in NYSE, the Dow...
-
Top 5 things to know in the market on Wednesday
Investing.com - Here are the top five things you need to know in financial markets on Wednesday, August 2: 1. Apple soars 6% on earnings beat Shares in {{erl-6408||Apple (NASDAQ:AAPL)...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.40%
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Basic Materials, Industrials and Financials sectors propelled shares higher. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
